By Nick Smith
Friday 29th November 2002 |
Text too small? |
The Health and Nutrition unit, which opened in Auckland yesterday, incorporates existing products from three legacy companies into one "specialty milk components innovator."
Chief executive Craig Norgate said the unit aimed to become the leader in the development and commercialisation of "bio-active ingredients for health and wellness."
Its opening was one of the key themes from "The Fonterra Strategy" and is expected to double existing earnings to about $80 million, he said.
Key markets for the specialty ingredients products include the US, Japan, Korea and China.
The "bio-actives market" had huge potential and "in the US alone, we expect to see growth double to a value of more than US$60 billion in the next four years," he said.
"By focusing on specialised research and development now, we will be well-placed to capture a good share of this growth, Mr Norgate said.
"The opportunities are virtually endless and we now have a strategy and discovery unit in place to identify, capture and maximise these returns to shareholders and ensuring that we stay ahead of the competition."
Key areas for the unit, headed by Patrick Geals from pharmaceutical giants Glaxo SmithKline and Novartis, to investigate include finding products that show benefits for the immune system, bone health, dermatology, gastrointestinal, sports and animal health.
No comments yet
HLG Full Year Results for the period ending 1 August 2025
TWR - Tower announces partnership with Westpac NZ
PaySauce charts Australian launch; reiterates guidance
September 26th Morning Report
Fonterra reports continued strong performance in FY25
Air NZ issues Australian $300 million Medium Term Notes
KMD - FY25 Annual Results Announcement
Tower successfully renews insurance programme for FY26
September 24th Morning Report
AIA - Auckland Airport considers bond offers